Table 2.

Correlation between the clinicopathologic variables and ACVR2B-AS1 expression.

Clinical characteristics	ACVR2B-AS1 expression
	Variable	No. of patients	High	%	Low	%	χ 2	p value
Age	<55	117	67	(31.75)	50	(31.45)	0	1.000
	≥55	253	144	(68.25)	109	(68.55)
Gender	Female	121	71	(33.65)	50	(31.25)	0.1417	0.6557
	Male	250	140	(66.35)	110	(68.75)
Histological type	Fibrolamellar	3	1	(0.47)	2	(1.25)	1.2706	0.515
	Hepatocellular	361	207	(98.1)	154	(96.25)
	Hepatocholangiocarcinoma	7	3	(1.42)	4	(2.5)
Histologic grade	G1	55	28	(13.46)	27	(17.09)	7.2563	0.054
	G2	177	97	(46.63)	80	(50.63)
	G3	122	72	(34.62)	50	(31.65)
	G4	12	11	(5.29)	1	(0.63)
Stage	I	171	92	(46.23)	79	(53.38)	2.8209	0.458
	II	86	50	(25.13)	36	(24.32)
	III	85	53	(26.63)	32	(21.62)
	IV	5	4	(2.01)	1	(0.68)
T Classification	T1	181	97	(46.19)	84	(52.83)	2.7575	0.647
	T2	94	56	(26.67)	38	(23.9)
	T3	80	47	(22.38)	33	(20.75)
	T4	13	9	(4.29)	4	(2.52)
	TX	1	1	(0.48)	0	(0)
N classification	N0	252	147	(70)	105	(65.62)	1.588	0.528
	N1	4	3	(1.43)	1	(0.62)
	NX	114	60	(28.57)	54	(33.75)
M Classification	M0	266	154	(72.99)	112	(70)	1.1272	0.597
	M1	4	3	(1.42)	1	(0.62)
	MX	101	54	(25.59)	47	(29.38)
Radiation therapy	No	338	191	(98.45)	147	(96.71)	0.5046	0.307
	Yes	8	3	(1.55)	5	(3.29)
Residual tumor	R0	324	183	(88.83)	141	(89.24)	0.8406	1.000
	R1	17	10	(4.85)	7	(4.43)
	R2	1	1	(0.49)	0	(0)
	RX	22	12	(5.83)	10	(6.33)
Vital status	Deceased	130	88	(41.71)	42	(26.25)	8.8834	0.003
	Living	241	123	(58.29)	118	(73.75)